Medtronic Lowers Earnings Forecast Following MiniMed IPO
ByAinvest
Thursday, Mar 26, 2026 4:00 pm ET1min read
MDT--
MMED--
Medtronic has lowered its FY26 earnings forecast after its diabetes spinoff, MiniMed, went public. The revised outlook includes a charge for future payments to private equity firm Blackstone, which funded development of MiniMed's new insulin pump. Medtronic now expects adjusted EPS of $5.50 to $5.54, a decrease of 12 cents from its previous forecast. The company expects dilution of one to two cents per month between the IPO and split.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet